Dissecting the Genetic & Molecular Heterogeneity of Kidney Diseases into Clinically Actionable Subtypes

Time: 2:15 pm
day: Track 2 - Day 1 PM


  • Employing biobank scale exome and genome sequencing in human populations to elucidate mechanisms underlying kidney disease in the general population
  • Developing and applying custom high-throughput metabolomic profiling to enable prediction of subjects with rapid progression of renal disease
  • Advancing patient segmentation through the integration of multi-omics and outcomes in clinically relevant segments